Phenotypic transitions and fibrosis in diabetic nephropathy (Q36753326)

16 August 2017

1 reference

title

Phenotypic transitions and fibrosis in diabetic nephropathy (English)

1 reference

16 August 2017

Simonson MS

1

1 reference

PubMed ID

17342177

16 August 2017

language of work or name

English

0 references

publication date

7 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

71

1 reference

16 August 2017

9

1 reference

16 August 2017

846-854

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002180

16 August 2017

0 references

cites work

Overview: combating diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Extracellular matrix metabolism in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Can renal fibrosis be reversed?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Toward a unified theory of renal progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Tubulointerstitial changes as a major determinant in the progression of renal damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

TGF-beta signal transduction and mesangial cell fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Renal fibrosis: new insights into the pathogenesis and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Epithelial-mesenchymal transition and its implications for fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Mechanisms of disease: Fibroblasts--a new look at an old problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Myofibroblast differentiation: plasma membrane microdomains and cell phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

TGF-beta signaling and the fibrotic response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Evidence that fibroblasts derive from epithelium during tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Extra-cellular matrix in vascular networks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

The role of extracellular matrix in postinflammatory wound healing and fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

How cells change their phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

The molecular basis of transdifferentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Nuclear reprogramming: a key to stem cell function in regenerative medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Teaching cells new tricks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Physiology of the mesangial cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Organ-Specific Collagen Expression: Implications for Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Mesangial matrix modulation and glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Identification and characterization of a fibroblast marker: FSP1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Myofibroblasts and mechano-regulation of connective tissue remodelling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Col1a2 enhancer regulates collagen activity during development and in adult tissue repair.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Myofibroblasts and the progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

The bone marrow functionally contributes to liver fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Bone marrow-derived progenitor cells in pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Bone marrow lacks a transplantable progenitor for smooth muscle type alpha-actin-expressing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Diversity, topographic differentiation, and positional memory in human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Metanephric mesenchyme contains embryonic renal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Granulocyte/macrophage origin of glomerular mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Stem cell approaches for the treatment of renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Stem cells and kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

The pathobiology of diabetic complications: a unifying mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Renal Bone Morphogenetic Protein-7 Protects against Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Inhibition of endogenous BMP in the glomerulus leads to mesangial matrix expansion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002180

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002180

1 reference

PubMed ID

17342177

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17342177